Fertility preservation in women with endometriosis: for all, for some, for none?
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The increasing confidence with the techniques of oocyte and ovarian cortex freezing has prompted their potential use for patient categories other than those at risk of early menopause due to cancer treatments. Women affected by every iatrogenic or pathologic condition known to compromise ovarian function severely have been considered as potential candidates for fertility preservation. Among them, women with endometriosis may represent a particularly suitable group since they are at increased risk of premature ovarian exhaustion and about half of them will experience infertility. Based on the currently available notions on the intricate relationships between endometriosis, infertility and damage to the ovarian reserve, we speculate that fertility preservation may be of interest for women with endometriosis, in particular for those with bilateral unoperated endometriomas and for those who previously had excision of unilateral endometriomas and require surgery for a contralateral recurrence. Young age at diagnosis may be an independent but pivotal additional factor to be taken into consideration in the balance of the pros and cons of fertility preservation. On the other hand, we argue against the introduction of fertility preservation for endometriosis in routine clinical practice. To date, only few cases have been reported and there are insufficient data for robust cost-utility analyses. It is noteworthy that endometriosis is a relatively common disease and systematically including affected women in a fertility preservation program would have profound clinical, logistic and financial effects. More clinical data and in-depth economic analysis are imperative prior to recommending its routine use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Self-citationRecurrence of endometriosis and its control
Guo, S.-W. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp007 · Cited by 719
Endometriosis: epidemiology and aetiological factors
Viganò, P., Parazzini, F., Somigliana, E., & Vercellini, P. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.01.007 · Cited by 718 · cited 3×
“On the other hand, it is noteworthy that endometriosis is a common condition, affecting 5–10% of reproductive age women (Viganò et al., 2004) and including all patients with a diagnosis of endometriosis in a fertility preservation program would have profound clinical, logistic and financial effects.”
BackgroundSelf-citationRaffi, F., Metwally, M., & Amer, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1558 · Cited by 546
Endometriosis fertility index: the new, validated endometriosis staging system
Adamson, G. D., & Pasta, D. J. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.035 · Cited by 483
Somigliana, E., Berlanda, N., Benaglia, L., Viganò, P., Vercellini, P., & Fedele, L. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.009 · Cited by 390
Self-citationSanchez, A. M., Viganò, P., Somigliana, E., Panina-Bordignon, P., Vercellini, P., & Candiani, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt053 · Cited by 357 · cited 3×
“Ovarian endometriomas are of particular concern here since these cysts contain a plethora of potentially toxic agents such as free iron that may diffuse through the cyst wall and damage the ovarian reserve (Sanchez et al., 2014).”
BackgroundInfluentialSelf-citationEnhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas
Kitajima, M., Dolmans, M.-M., Donnez, O., Masuzaki, H., Soares, M., & Donnez, J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.049 · Cited by 229 · cited 1×
“Recent histological insights showed a significant reduction of the pool of primordial follicles in the ovarian cortex of affected gonads (Kitajima et al., 2011, 2014).”
BackgroundBrosens, I., Gordts, S., & Benagiano, G. (2013) · Human Reproduction · doi:10.1093/humrep/det243 · Cited by 184
Endometriotic ovarian cysts negatively affect the rate of spontaneous ovulation
Benaglia, L., Somigliana, E., Vercellini, P., Abbiati, A., Ragni, G., & Fedele, L. (2009) · Human Reproduction · doi:10.1093/humrep/dep202 · Cited by 148 · cited 2×
“In women with unilateral endometriomas, ovulation occurs less frequently in the affected ovary (Horikawa et al., 2008; Benaglia et al., 2009) but ovarian responsiveness to hyperstimulation and oocyte competence is similar (Almog et al.”
BackgroundSelf-citation
Cited by
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Endometriosis-associated infertility: From pathophysiology to tailored treatment
Bonavina, G., & Taylor, H. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1020827 · Cited by 319
A prospective cohort study of endometriosis and subsequent risk of infertility
Prescott, J., Farland, L. V., Tobias, D. K., Gaskins, A. J., Spiegelman, D., Chavarro, J. E., Rich-Edwards, J. W., Barbieri, R. L., & Missmer, S. A. (2016) · Human Reproduction · doi:10.1093/humrep/dew085 · Cited by 309
Oocyte vitrification for fertility preservation for both medical and nonmedical reasons
Cobo, A., García-Velasco, J. A., Remohí, J., & Pellicer, A. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.02.006 · Cited by 165
Oocyte vitrification for fertility preservation in women with endometriosis: an observational study
Cobo, A., Giles, J., Paolelli, S., Pellicer, A., Remohí, J., & García-Velasco, J. A. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.017 · Cited by 127
Bourdon, M., Raad, J., Dahan, Y., Marcellin, L., Maignien, C., Even, M., Pocate-Cheriet, K., Lamau, M. C., Santulli, P., & Chapron, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0202399 · Cited by 42
Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis
Kim, S. J., Kim, S. K., Lee, J. R., Suh, C. S., & Kim, S. H. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.01.028 · Cited by 42
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
“Oocytes cryopreservation may be considered, but to date, it remains an experimental approach.(252)”
BackgroundSelf-citationEndometriosis and Fertility Preservation
BARNETT, R., BANKS, N., & DECHERNEY, A. H. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000311 · Cited by 31
Metadata
- Authors
- Somigliana, E., Vigano, P., Filippi, F., Papaleo, E., Benaglia, L., Candiani, M., & Vercellini, P.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-16
- Volume
- 30
- Issue
- 6
- Pages
- 1280-1286
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2035183035
- Cited by
- 128
- References
- 14
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.